Meropenem Atral

Meropenem, the active ingredient in Meropenem Atral, is a carbapenem antibiotic presented as an injection for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, pneumonia, meningitis, and sepsis in hospitalized patients.

GNH USA supplies Meropenem Atral as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide through regulated distribution channels.

Meropenem is a broad‑spectrum carbapenem antibiotic used for serious bacterial infections affecting various organ systems.

- Complicated intra‑abdominal infections: provides rapid bactericidal activity to resolve infection. - Complicated skin and soft tissue infections: eradicates resistant pathogens and promotes healing. - Community‑acquired and hospital‑acquired pneumonia: achieves high lung tissue concentrations for effective treatment. - Meningitis: penetrates the cerebrospinal fluid to eliminate causative organisms. - Severe sepsis and septic shock: offers broad coverage to control systemic infection.

Adverse reactions may occur with any antibiotic and should be monitored during therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Rash: erythematous skin eruption. - Headache: transient and usually resolves. - Elevated liver enzymes: mild transaminase increase. - Injection site pain: local discomfort.

Serious or Rare Side Effects: - Seizures: especially in patients with CNS disorders or renal impairment. - Clostridioides difficile colitis: severe diarrhea requiring medical attention. - Anaphylaxis: acute hypersensitivity reaction. - Severe neutropenia: marked reduction in white blood cells. - Acute renal failure: worsening kidney function. - Hypersensitivity reactions: including Stevens‑Johnson syndrome.

Careful assessment and monitoring are required to minimize risks associated with meropenem therapy.

- Renal function assessment: adjust dosing in patients with impaired renal clearance. - Monitor for seizures: avoid in individuals with a history of epilepsy or CNS disease. - Check for hypersensitivity: discontinue immediately if allergic signs appear. - Use with caution in elderly: increased susceptibility to neurotoxicity. - Avoid concomitant valproic acid: may raise seizure risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Valproic acid: heightened seizure potential. - CNS depressants: additive neurotoxic effects. - Renally toxic drugs: may exacerbate kidney injury.

Moderate Interactions (Monitor Closely): - Loop diuretics: possible electrolyte disturbances. - Aminoglycosides: increased risk of nephrotoxicity. - Warfarin: potential alteration of INR requiring monitoring.